Related Experiment Videos
Staging procedures in mycosis fungoides
The British Journal of Cancer. Supplement
|March 1, 1975
Summary
Deep-seated mycosis fungoides (MF) in organs like lymph nodes, spleen, or liver often resists topical treatment. Surgical staging is crucial for identifying extracutaneous disease and guiding new therapeutic strategies.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Mycosis fungoides (MF) is a type of cutaneous T-cell lymphoma.
- Extracutaneous involvement of MF in deep-seated organs can impact treatment response.
- Topical therapies may be less effective when MF spreads beyond the skin.
Purpose of the Study:
- To investigate the prevalence of deep-seated mycosis fungoides (MF) in lymph nodes, spleen, and liver.
- To assess the association between extracutaneous MF and response to topical therapy.
- To evaluate the utility of surgical staging in determining the extent of disease.
Main Methods:
- Clinical staging of 14 patients with mycosis fungoides.
- Performance of staging laparotomy in all patients.
- Histopathological examination of lymph nodes, spleen, and liver for MF.
- Correlation of findings with clinical presentation (adenopathy, splenomegaly, abnormal spleen scans).
Main Results:
- Mycosis fungoides was detected in the lymph nodes of 3 patients.
- Splenic involvement by MF was found in 4 patients.
- Liver involvement was identified in 2 patients.
- Extracutaneous MF was documented in a significant proportion of patients.
Conclusions:
- Deep-seated mycosis fungoides in lymph nodes, spleen, or liver is associated with poor response to topical treatments.
- Surgical staging is recommended for patients with adenopathy or splenomegaly to assess extracutaneous disease extent.
- Accurate documentation of extracutaneous MF is essential for developing novel therapeutic strategies.